Gastrointestinal Endoscopy
Volume 70, Issue 5 , Pages 881-887 , November 2009

Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis

Received 30 September 2008 ,Accepted 20 March 2009.

References 

  1. The Burden of Gastrointestinal Diseases. Bethesda (Md): American Gastroenterological Association; 2001;41-2
  2. de Francis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5:645–663
  3. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology. 2004;126:1175–1189
  4. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc. 1986;32:264–268
  5. Chey WD, Elta GH. Natural history of gastric varices. Gastroenterology. 1993;105:599–602
  6. Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertensive patients. Hepatology. 1992;16:1343–1349
  7. Matsumoto A, Takimoto K. Gastric fundal varices: new aspects of non-surgical treatment in Japan. Nat Clin Pract Gastroenterol Hepatol. 2006;3:4–5
  8. Rengstorff DS, Binmoeller KF. A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans. Gastrointest Endosc. 2004;59:553–558
  9. Mahadeva S, Bellamy MC, Kessel D, et al. Cost effectiveness of n-butyl-2-cyanoacrylate (Histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding. Am J Gastroenterol. 2003;98:2688–2693
  10. D'Imperio N, Piemontese A, Baroncini D, et al. Evaluation of undiluted n-butyl-2-cyanoacrylate in the endoscopic treatment of upper gastrointestinal tract varices. Endoscopy. 1996;28:239–243
  11. Miyazaki S, Yoshida T, Harada T, et al. Injection sclerotherapy for gastric varices using n-butyl-2-cyanoacrylate and ethanolamine oleate. Hepatogastroenterology. 1998;45:1155–1158
  12. Ogawa K, Ishikawa S, Naritaka Y, et al. Clinical evaluation of endoscopic injection sclerotherapy using n-butyl-2-cyanoacrylate for gastric variceal bleeding. J Gastroenterol Hepatol. 1999;14:245–250
  13. Kind R, Gugliemi A, Rodella L, et al. Bucrylate treatment of bleeding gastric varices: 12 years' experience. Endoscopy. 2000;32:512–519
  14. Caldwell SH, Hespenheide EE, Greenwald BD, et al. Enbucrilate for gastric varices: extended experience in 92 patients. Aliment Pharmacol Ther. 2007;26:49–59
  15. Rossle M, Haag K, Ochs A, et al. Transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994;330:165–171
  16. Social Security Death Index. Available at: http://ssdi.rootsweb.ancestry.com/. Accessed January 10, 2008.
  17. ter Borg PCG, Hollemans M, van Buuren HR, et al. Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results for a cohort observed for 3-9 years. Radiology. 2004;237:537–545
  18. Tripathi D, Ferguson JW, Therapondos G, et al. Review article: recent advances in the management of bleeding gastric varices. Aliment Pharmacol Ther. 2006;24:1–17
  19. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveeno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–176
  20. Greenwald BD, Caldwell SH, Hespenheide EE, et al. N-2-butyl cyanoacrylate for bleeding gastric varices, a United States pilot study and cost analysis. Am J Gastroenterol. 2003;98:1982–1988
  21. Lake JR. The role of transjugular portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1745–1747

 DISCLOSURE: All authors disclosed no financial relationship relevant to this publication.

 See CME section; p. 976.

PII: S0016-5107(09)01702-7

doi: 10.1016/j.gie.2009.03.1169

Gastrointestinal Endoscopy
Volume 70, Issue 5 , Pages 881-887 , November 2009

Article Tools

* Image Usage & Resolution